Crizotinib in advanced ROS1-rearranged non-small cell lung cancer (NSCLC): Updated results from PROFILE 1001 Meeting Abstract


Authors: Shaw, A.; Riley, G. J.; Bang, Y. J.; Kim, D. W.; Camidge, D. R.; Varella-Garcia, M.; Lafrate, A. J.; Shapiro, G.; Winter, M.; Usari, T.; Wang, S. C.; Wilner, K.; Clark, J. W.; Ou, S. H. I.
Abstract Title: Crizotinib in advanced ROS1-rearranged non-small cell lung cancer (NSCLC): Updated results from PROFILE 1001
Meeting Title: 41st European Society for Medical Oncology Congress (ESMO)
Journal Title: Annals of Oncology
Volume: 27
Issue: Suppl. 6
Meeting Dates: 2016 Oct 7-11
Meeting Location: Copenhagen, Denmark
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2016-10-01
Start Page: vi418
Language: English
ACCESSION: WOS:000393913000299
PROVIDER: wos
DOI: 10.1093/annonc/mdw383.07
Notes: Meeting Abstract: 1206PD -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Glendora Riley
    1 Riley